ask="5.65"
ask_size="600"
average_daily_volume="527337"
bid="3.81"
bid_size="100"
book_value="2.30"
change="-0.02"
change_from_200_day_moving_average="-0.24"
change_from_50_day_moving_average="0.14"
change_from_52_week_high="-2.30"
change_From_52_week_low="1.40"
change_in_percent="-0.44%"
close="4.50"
dividend_pay_date="12/30/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.68"
ebitda="-43.09M"
eps_estimate_current_year="-1.47"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.84"
ex_dividend_date="12/31/2013"
float_shares="40197000"
high="4.57"
high_52_weeks="6.80"
last_trade_date="2/17/2017"
last_trade_price="4.50"
last_trade_size="1788"
last_trade_time="4:00pm"
low="4.39"
low_52_weeks="3.10"
market_capitalization="294.42M"
moving_average_200_day="4.74"
moving_average_50_day="4.36"
name="Aralez Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="8.75"
open="4.50"
pe_ratio="N/A"
peg_ratio="-0.10"
percent_change_from_200_day_moving_average="-5.14%"
percent_change_from_50_day_moving_average="+3.22%"
percent_change_from_52_week_high="-33.82%"
percent_change_from_52_week_low="+45.16%"
previous_close="4.52"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.96"
price_per_sales="7.35"
revenue="40.23M"
shares_outstanding="65427000"
short_ratio="8.92"
stock_exchange="NMS"
symbol="ARLZ"
volume="153961"
weeks_range_52="3.10 - 6.80"
